Benzinga | Aug 9, 2021 09:14AM EDT

Edgewise Therapeutics Q2 EPS $(0.21) Up From $(7.43) YoY

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.21) per share. This is a 97.17 percent increase over losses of $(7.43) per share from the same period last year.